Global Calcium Folinate Market Insights, Forecast to 2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Calcium Folinate Market Insights, Forecast to 2034
Calcium Folinate, also known as leucovorin calcium, is a drug similar to folic acid. Commonly used as an antidote to an overdose of antifolate metabolites, as well as Megaloblastic anemia and Leukopenia.
Market Analysis and InsightsGlobal Calcium Folinate Market
Global Calcium Folinate market is expected to reach to US$ 105 million in 2023, with a positive growth of %, compared with US$ 97 million in 2022. Backed with the increasing demand from downstream industries, Calcium Folinate industry is evaluated to reach US$ 167.5 million in 2033. The CAGR will be 8.1% during 2023 to 2033.
Globally, Calcium Folinate key companies include Merck, Teva, Ingenus, Mylan, West-Ward Pharmaceuticals, Sagent Pharmaceuticals, Fresenius Kabi USA, Hubei Jusheng Technology and Major Pharmaceuticals, etc. Merck, Teva, Ingenus are top 3 players and held % share in total in 2022.
When considering the consumption regions, % revenue of Calcium Folinate were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033 and the share will be % in 2033. Moreover, China, plays a key role in the whole Calcium Folinate market and estimated to attract more attentions from industry insiders and investors.
Calcium Folinate can be divided into Tablet, Injection and Capsule,, etc. Tablet is the mainstream product in the market, accounting for % revenue share globally in 2022 and the proportion will be % in 2033.
Calcium Folinate is widely used in various fields, such as Retail Pharmacies, Hospital Pharmacies and Online Pharmacies,, etc. Retail Pharmacies provides greatest supports to the Calcium Folinate industry development. In 2022, global % revenue of Calcium Folinate went into Retail Pharmacies filed and the proportion will reach to % in 2033.
Report Covers
This report presents an overview of global Calcium Folinate market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Calcium Folinate market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
Merck
Teva
Ingenus
Mylan
West-Ward Pharmaceuticals
Sagent Pharmaceuticals
Fresenius Kabi USA
Hubei Jusheng Technology
Major Pharmaceuticals
American Health Packaging
BluePoint Laboratories
Segment by Type
Tablet
Injection
Capsule
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Calcium Folinate introduction, etc. Calcium Folinate Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Calcium Folinate
Chapter 13Methodology and Data Sources adopted by MRAResearch
Market Analysis and InsightsGlobal Calcium Folinate Market
Global Calcium Folinate market is expected to reach to US$ 105 million in 2023, with a positive growth of %, compared with US$ 97 million in 2022. Backed with the increasing demand from downstream industries, Calcium Folinate industry is evaluated to reach US$ 167.5 million in 2033. The CAGR will be 8.1% during 2023 to 2033.
Globally, Calcium Folinate key companies include Merck, Teva, Ingenus, Mylan, West-Ward Pharmaceuticals, Sagent Pharmaceuticals, Fresenius Kabi USA, Hubei Jusheng Technology and Major Pharmaceuticals, etc. Merck, Teva, Ingenus are top 3 players and held % share in total in 2022.
When considering the consumption regions, % revenue of Calcium Folinate were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033 and the share will be % in 2033. Moreover, China, plays a key role in the whole Calcium Folinate market and estimated to attract more attentions from industry insiders and investors.
Calcium Folinate can be divided into Tablet, Injection and Capsule,, etc. Tablet is the mainstream product in the market, accounting for % revenue share globally in 2022 and the proportion will be % in 2033.
Calcium Folinate is widely used in various fields, such as Retail Pharmacies, Hospital Pharmacies and Online Pharmacies,, etc. Retail Pharmacies provides greatest supports to the Calcium Folinate industry development. In 2022, global % revenue of Calcium Folinate went into Retail Pharmacies filed and the proportion will reach to % in 2033.
Report Covers
This report presents an overview of global Calcium Folinate market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Calcium Folinate market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
By Company
Merck
Teva
Ingenus
Mylan
West-Ward Pharmaceuticals
Sagent Pharmaceuticals
Fresenius Kabi USA
Hubei Jusheng Technology
Major Pharmaceuticals
American Health Packaging
BluePoint Laboratories
Segment by Type
Tablet
Injection
Capsule
Segment by Application
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Calcium Folinate introduction, etc. Calcium Folinate Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Calcium Folinate
Chapter 13Methodology and Data Sources adopted by MRAResearch